About a third of endometriosis patients using cannabis reported side effects, but some of those effects might actually be helpful

Among endometriosis patients using cannabis for symptom management, 32% experienced side effects, consistent with published literature. However, the study suggests that some reported adverse effects may have clinical utility in the endometriosis population and require more nuanced interpretation.

Subset analysis of a larger international survey (n=889) investigating self-reported effectiveness, safety, and pharmaceutical de-prescribing trends of cannabis use among people with endometriosis.

Endometriosis patients are increasingly turning to cannabis for pain management, often without medical guidance. Reframing certain "side effects" as potentially beneficial challenges the binary categorization of drug effects and could inform more patient-centered care.

The concept that a side effect in one context can be therapeutic in another is well-established in medicine (sedation as a side effect vs. a sleep aid). This study applies that lens to cannabis use in endometriosis, where symptoms like poor appetite, insomnia, and anxiety often co-occur with pain.

Survey-based self-reported data. Subset of a larger study, so the specific sample size for this analysis is unclear. No clinical verification of endometriosis diagnosis or cannabis use. International sample with varying legal and product quality contexts.